Difference of Gene Expression in Venous Malformation |
Kim, Taek Kyun
(Department of Plastic and Reconstructive Surgery, School of Medicine, Kyungpook National University)
Oh, Eun Jung (Department of Advanced Material Engineering, School of Engineering, Kyungpook National University) Cho, Byung Chae (Department of Plastic and Reconstructive Surgery, School of Medicine, Kyungpook National University) Chung, Ho Yun (Department of Plastic and Reconstructive Surgery, School of Medicine, Kyungpook National University) |
1 | Mulliken JB, Glowacki J: Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 69: 412, 1982 DOI ScienceOn |
2 | Chaft JE, Steckman DA, Blei F: Genetics of vascular anomalies; an update. Lymphat Res Biol 1: 283, 2003 DOI |
3 | Lindahl P, Johansson BR, Leveen P, Betsholtz C: Pericyte loss and microaneurysm formation in PDGF-Beficient mice. Science 277: 242, 1997 DOI ScienceOn |
4 | Vikkula M, Boon LM, Mulliken JB: Molecular genetics of vascular malformations. Matrix Biol 20: 327, 2001 DOI ScienceOn |
5 | Korpelainen EI, Karkkainen M, Gunji Y, Vikkula M, Alitalo K: Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene 18: 1, 1999 DOI |
6 | Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161, 1996 DOI ScienceOn |
7 | Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin 2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55, 1997 DOI ScienceOn |
8 | Vikkula M, Boon LM, Mulliken JB, Olsen BR: Molecular basis of vascular anomalies. Trends Cardiovasc Med 8: 281, 1998 DOI ScienceOn |
9 | Hwang IT, Kim YJ, Kim SH, Kwak CI, Gu YY, Chun JY: Annealing control primer system for improving specificity of PCR amplification. Biotechniques 35: 1180, 2003 |
10 | Chiller KG, Frieden IJ, Arbiser JL: Molecular pathogenesis of vascular anomalies: classification into three categories based upon clinical and biochemical characteristics. Lymphat Res Biol 1: 267, 2003 DOI ScienceOn |
11 | Hwang DY, Cho JS, Oh JH, Shim SB, Jee SW, Lee SH, Seo SJ, Lee SK, Lee SH, Kim YK: Differentially expressed genes in transgenic mice carrying human mutant presenilin-2(N1411): correlation of selenoprotein M with Alzheimer's disease. Neurochem Res 30: 1009, 2005 DOI |
12 | Vikkula M, Boon LM, Carraway KL 3rd, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR: Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87: 1181, 1996 DOI ScienceOn |
13 | Enjolras O, Mulliken JB: Vascular tumors and vascular malformations(new issues). Adv Dermatol 13: 375, 1997 |
14 | Gallione CJ, Pasyk KA, Boon LM, Lennon F, Johnson DW, Helmbold EA, Markel DS, Vikkula M, Mulliken JB, Warman ML, Pericak-Vance MA, Marchuk DA: A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet 32:197, 1995 DOI |
15 | Morris PN, Dunmore BJ, Tadros A, Marchuk DA, Darland DC, D'Amore PA, Brindle NP: Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations. J Mol Med 83: 58, 2005 DOI |